Olaparib hy 10162
Olaparib (HY-10162) is a poly(ADP-ribose) polymerase (PARP) inhibitor. It is a small molecule that functions by blocking the activity of PARP enzymes, which are involved in DNA repair processes.
Lab products found in correlation
4 protocols using olaparib hy 10162
Liver Cancer Cell Lines and Reagents
Multimodal Combination Therapy for Cancer
Investigating LPS-Induced AKI via PARP1
The DLT (batch number: 20140302) was purchased from Jilin Connell Pharmaceutical Co. Ltd., China. LPS (O111: B4, L2630) was purchased from Sigma-Aldrich (St. Louis, MO, USA). Olaparib (HY-10162) was obtained from MedChemExpress (NJ, USA). GSSG, MDA, DHE, DAPI, and Hoechst 33342 were purchased from Beyotime Biotechnology (Shanghai, China). ELISA kits for mouse TNF-α, IL-6, and IL-1β and microplate assay kits for creatinine and blood urea nitrogen were provided by Jianglai Co., Ltd. (Shanghai, China). HE and PAS staining kit were purchased from Solarbio (Beijing, China). Primary antibody sources are as follows: PARP1 (DF7198; Affinity, OH, USA), HMGB1 (ab79823; Abcam, Cambridge, UK), and β-actin (AC026; ABclonal, Wuhan, China).
Cell Line Cultivation and Drug Treatment
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!